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Invasive aspergillosis is the primary opportunistic invasive fungal
infection described in neutropenic hematologic patients, caused by
the angioinvasive pathogen Aspergillus fumigatus. The molecular
mechanisms associated with A. fumigatus infection in the vascular
endothelium are poorly understood. In this context, we used a
high-throughput proteomic approach to unveil the proteins
modulated in HUVECs after interaction with a wild type strain and
the UGM1 mutant (Δugm1) of A. fumigatus. The proteomic analysis
was also performed in HUVECs challenged with a galactosamino-
galactan (GAG) puriﬁed from A. fumigatus cell wall. The dataset
presented here correspond to all proteins identiﬁed that ﬁt a 2-fold
change criteria (log 2 ratio Z 1 or r 1), disregarding the sta-
tistical validation cut off, in order to supplement the research
article entitled “Modiﬁcations to the composition of the hyphal
outer layer of Aspergillus fumigatus modulates the HUVEC proteinsis an open access article under the CC BY license
/j.jprot.2016.06.015
om (L.M. Lopes-Bezerra).
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G.W.P. Neves et al. / Data in Brief 9 (2016) 24–31 25associated with inﬂammatory and stress responses” (G.W.P. Neves,
N.A. Curty, P.H. Kubitschek-Barreira, T. Fontaine, G.H.M.F. Souza, M.
Lyra Cunha, G.H. Goldman, A. Beauvais, J.P. Latgé, L.M. Lopes-
Bezerra, 2016) [1]. The mass spectrometry proteomic data have
been deposited in the ProteomeXchange Consortium via the PRIDE
partner repository with the dataset identiﬁer PRIDE: PXD002823.
& 2016 Published by Elsevier Inc. This is an open access article
under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
ore speciﬁc sub-
ject areaMedical Mycologyype of data Table, image, ﬁgure
ow data was
acquiredScanning electron microscope JEOL JSM-6510 LV, Fluorescence Microscope,
nanoACQUITY UHPL System Waters, Synapt G2-S Waters.ata format Filtered, Analyzed
xperimental
factorsConﬂuent HUVEC monolayers were infected with thimerosal-treated germlings
of the wild type and Δugm1 strains of Aspergillus fumigatus and the puriﬁed
GAG. After 16 hours of infection, an extract of whole HUVEC protein was
obtained.xperimental
featuresAll HUVEC protein extracts were analyzed using a 2D-nanoLC-HDMSE approach.ata source
locationRio de Janeiro, Brazilata accessibility Data is within this article and deposited in the ProteomeXchange Consortium via
the PRIDE partner repository with the dataset identiﬁer PRIDE: PXD002823.Value of the data
 This dataset will be of value to the scientiﬁc community aiming to analyze the identiﬁed proteins
modulated in HUVECs upon infection by A. fumigatus and the participation of the cell wall galac-
tosaminogalactan (GAG) in endothelial activation.
 This data article contributes to the scientiﬁc research concerning the role of GAG in the physio-
pathology of invasive aspergillosis.
 The data provided here identify key proteins involved in the response of HUVECs to different
strains of A. fumigatus, contributing to the knowledge of angioinvasive molecular mechanism in
invasive aspergillosis.1. Data
Fig. 1 shows an increased GAG cell wall expression by the Δugm1 strain of A. fumigatus and, Fig. 2
further illustrates the interaction of HUVECs monolayers with germlings of all A. fumigatus strains.
Supplementary tables 1–3 present the respective list of identiﬁed HUVEC proteins, including the
difference in the abundance levels, in the following interaction conditions: Δugm1 vs. control; WT vs.
control; Δugm1 vs. WT; and GAG vs control. Figs. 3–5 show the pathways that were predicted by
Ingenuity Pathway Analysis (IPA) modulated in HUVECs challenged with the UGM1 mutant and the
puriﬁed cell wall GAG.
Fig. 1. A The germlings (A–F) and swollen conidia (G–I) of A. fumigatus wild type (A, D and G) Δugm1 (B, D and H) and Δugm1:
ugm1 (C, F and I). Δugm1 showed increased production on an amorphous thin substance typical of A. fumigatus ECM (arrows).
Swollen Δugm1 conidia (H) released a ﬁlament from the wall that apparently adhered to the coverslip (arrows). Bars: A–C 5 mm.
D–I ¼1 mm. B: Detection of galactosaminogalactan using immunoﬂuorescence on germinated conidia. The mutant showed an
increased amount of GAG on the cell wall of germinated conidia and an adherent secreted material in the Δugm1 (arrows).
Bars: 10 mm.
Fig. 2. SEM of HUVECs monolayers challenged with the germlings of different strains of A. fumigatus. HUVEC interaction with
the wild type (A), Δugm1 (B) and Δugm1:ugm1 (C) strains. Bars: A–C 5 mm.
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Fig. 3. Ingenuity pathway analysis (IPA) showing the commonly regulated HUVEC routes of the Δugm1 mutant of A. fumigatus
based on the following comparisons: Δugm1 vs. uninfected control and Δugm1 vs. WT. The graph shows the main routes
regulated through Δugm1, indicating the number of proteins with higher-abundance (black) and lower-abundance (gray)
levels. For this analysis, we used the quantitation criteria of a minimum 2.0-fold change.
Fig. 4. Ingenuity pathway analysis (IPA) showing the HUVEC routes commonly regulated through GAG and the Δugm1 mutant
compared with the HUVEC uninfected control. The graphic shows the number of proteins with higher-abundance (black) and
lower-abundance (gray) levels. For this analysis, we used the quantitation criteria of a minimum 2.0-fold change.
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2.1. Strains, culture conditions and microscopic analysis of the fungal cell surface
The Ku80 pyrGþ parental strain (WT) [2], the UGM1 mutant (Δugm1) and the reconstituted strain
(Δugm1:ugm1) [3] were cultivated as previously described [1,4]. The puriﬁed urea-soluble fraction of
galactosaminogalactan (GAG) was obtained as described [5].
For scanning electron microscopy (SEM), the conidia were placed on glass coverslips coated with
2% gelatin and incubated in Sabouraud broth for 6 h at 37 °C, to obtain the germ tubes (germlings).
After, germlings were washed in PBS and ﬁxed for 1 h with 2.5% glutaraldehyde plus 4% paraf-
ormaldehyde in 0.1 M calcodylate buffer (pH 7.2), washed three times with the same buffer and post-
ﬁxed with 1% osmium tetroxide. The cells were subsequently dehydrated in a graded ethanol series
Fig. 5. Illustration of the ILK signaling pathway generated using QIAGEN's Ingenuity
s
Pathway Analysis, differentially regulated
under GAG interaction conditions. The proteins in red and green indicate higher and lower abundance levels under GAG inter-
action conditions, respectively. In addition, the ﬁgure also illustrates that TNF-α participates in the upstream regulation of this
pathway. The arrows indicate predicted regulation, activation (-) or inhibition (‘). The proteins used in this analysis were
ﬁltered using the following criteria: minimum of 2.0-fold change and quantitation ANOVA, p-value r 0.05. ECM protein-
extracellular protein; FAK - Focal adhesion kinase; PI3K  1 Phosphatidyl inositol 3 kinase; ILKAP - Integrin-linked kinase-
associated serine/threonine phosphatase 2C; ILK - Integrin-linked protein kinase; PARVβ- Parvin beta; RICTOR - Rapamycin-
insensitive companion of mTOR; PXN – Paxilin; VCL – Vinculin; Filamin-binding LIM protein 1; KIND2 - Fermitin family homolog
2; TESK1 - Dual speciﬁcity testis-speciﬁc protein kinase 2; PARVα - Parvin alpha; PDK1  3-phosphoinositide-dependent protein
kinase 1; AKT - Protein Kinase B; CASP3 - Caspase-3; PIP3 - Phosphatidylinositol (3,4,5)-trisphosphate; PIP2 - phosphatidyli-
nositol biphosphate; PI3K  1 Phosphatidyl inositol 3 kinase; PTEN - Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and
dual-speciﬁcity protein phosphatase PTEN; IRS - Insulin receptor substrate; PINCH - LIM and senescent cell antigen-like-con-
taining domain protein; TB4 - Thymosin beta-4; RSU1 - Ras suppressor protein 1; RTK - Receptor tyrosine kinase; PP2A - Protein
phosphatase 2A; NCK2 - Cytoplasmic protein NCK2; DOCK 180 - Dedicator of cytokinesis protein 180; TNFR - tumor necrosis
factor receptor; GSK3 - Glycogen synthase kinase-3; JNK - c-Jun N-terminal Protein Kinase; mTOR - Serine/threonine-protein
kinase mTOR; NACA - Nascent polypeptide-associated complex subunit alpha; ERK 1/2 - Mitogen-activated protein kinase ERK 1/
2; CTNNβ - Catenin (Cadherin-Associated Protein), Beta; MSK 1/2 - Mitogen and stress activated protein kinase 1/2; CREB - Cyclic
AMP-responsive element-binding protein; LEF 1- Lymphoid enhancer-binding factor 1; cJUN – Jun Proto-Oncogene; cFOS – FBJ
Murine Osteosarcoma viral oncogene homolog; HIF 1α - Hypoxia-inducible factor 1-alpha; c-MYC - Myc proto-oncogene protein;
iNOS - Nitric oxide synthase, inducible; COX2 - Prostaglandin G/H synthase 2; MMP9 - Matrix metalloproteinase-9; VEGF -
Vascular endothelial growth factor; SLUG - Zinc ﬁnger protein SNAI2; FN1 – Fibronectin; RHO - Ras-like GTP-binding protein Rho;
DSP – Desmoplakin; KRT 18 - Keratin, type I cytoskeletal 18; MUC – Mucin; VIM – Vimentin. (For interpretation of the references
to color in this ﬁgure legend, the reader is referred to the web version of this article).
G.W.P. Neves et al. / Data in Brief 9 (2016) 24–3128and critical point-dried with CO2. The specimens were coated with gold in a Balzers sputtering
apparatus and the micrographs were captured using a JEOL JSM-6510 LV SEM. The images were
processed using ImageJ software. The obtained scanning electron microscopy (SEM) images of
G.W.P. Neves et al. / Data in Brief 9 (2016) 24–31 29germlings of different A. fumigatus strains are shown in Fig. 1A. This experiment was performed twice
with experimental duplicates.
For GAG immunolabeling, the conidia were germinated overnight in Brian's medium [6] on eight-
well Permanox chamber slides (Lab-Tek
s
) at 30 °C and further ﬁxed with 2.5% (w/v) paraformalde-
hyde for 2 h at room temperature. After ﬁxation, the cells were washed with 0.1 M NH4Cl in PBS for
5 min, followed by incubation with 5% goat serum in PBS for 1 h. The cells were incubated with an
anti-galactosaminogalactan monoclonal antibody (kindly provided from Dr. Jean-Paul Latgé, Pasteur
Institute, Paris) at 20 mg/ml in 5% goat serum/PBS for 1 h at room temperature. After washing with
goat serum/PBS, the cells were incubated with goat TRITC-conjugated anti-mouse IgG(HþL) (Sigma)
diluted 1:200 in goat serum/PBS. After washing with PBS, hyphae of A. fumigatus strains were
visualized with a ﬂuorescence light microscope, and the images are shown in Fig. 1B. A mock
monoclonal antibody was used as a control. This experiment was performed three times with
experimental duplicates.
2.2. Culture of human vein endothelial cells (HUVEC) and interaction assay
HUVECs were obtained as previously described in [1,7]. The use of HUVECs was approved through
the Research Ethics Committee of the Municipal Health Secretary and Civil Defense of Rio de Janeiro
(CEP SMSDC-RJ), protocol no. 196/09. In total, 18 volunteers participated in the present study.
For the interaction assays, HUVEC monolayers were infected with germlings of A. fumigatus WT
and Δugm1 strains, and with puriﬁed GAG (1 mg/mL), as described previously [1]. Uninfected HUVEC
monolayers (control) were maintained in the same culture conditions. For SEM the HUVEC assays
were performed as described above, section 1.1. The SEM images of HUVEC monolayers challenged
with germlings of all A. fumigatus strains are shown in Fig. 2.
2.3. Label-free protein analysis using mass spectrometry, database searching and quantiﬁcation
The proteins extracts used for proteomics assays were obtained as follows. The endothelial cell
monolayers cultivated on 75-cm2 culture ﬂasks were infected with thimerosal-killed germlings of A.
fumigatus [4] or were interacted with the puriﬁed GAG. After, HUVEC monolayers were washed twice
with Hank´s balanced salt solution (Cultilab) and gently harvested using a cell scraper. Next, the cells
were centrifuged at 200 g, for 10 min. The pellet was subsequently suspended in 250 mL of a lysis
buffer (8 M urea, 1 M Tris, 4% (w/v) CHAPS, supplemented with 1 mM PMSF, 5 mM EDTA, 160 mM
leupeptin, 1 mM pepstatin, and 0.125 units/ml benzonase) and incubated for 1 h at 4 °C. Subsequently,
the cell lysate was centrifuged at 13,000 g, for 15 min at 4 °C, and the supernatants (protein extracts)
were collected and stored at 80 °C. After extraction, the proteins were quantiﬁed using a Bradford
assay and analyzed as previously described [8]. Brieﬂy, 50 mg of each extract was concentrated, and
the lysis buffer was exchanged with 50 mM ammonium bicarbonate using a 3-kDa ultra-ﬁltration
device (Millipore). The protein extract was denatured (0.1% RapiGEST SF at 60 °C for 15 min) (Waters,
Milford, USA), reduced using DTT (10 mM DTT at 60 °C for 30 min), alkylated with IAA (10 mM IAA at
room temperature for 30 min in the dark) and enzymatically digested with trypsin (Promega,
Madison, USA) at a 1:50 (w/w) enzyme:protein ratio. This reaction was terminated after the addition
of 10 mL of 5% triﬂuoroacetic acid (TFA), and the internal standard, yeast alcohol dehydrogenase
(P00330), was added to the digests to achieve 10 fmol μL1 per injection [9,10]. Qualitative and
quantitative bi-dimensional nanoUPLC tandem nanoESI-HDMSE experiments were conducted using a
1 h reverse-phase gradient from 7% to 40% (v/v) acetonitrile (0.1% v/v formic acid) at 500 nL min1 on
a nanoACQUITY UPLC 2D Technology system. A nanoACQUITY UPLC HSS T3 1.8 mm, 75 mm15 cm
column (pH 3) was used in conjunction with a reversed phase (RP) XBridge BEH130 C18 5 mm 300 mm
x 50 mm nanoﬂow column (pH 10). A typical on-column sample load was 500 ng of total protein
digests for each of the ﬁve fractions (500 ng/fraction/load). The resolving power for all measurements
was at least 35,000 FWHM, and the ion mobility cell, ﬁlled with nitrogen gas, had a cross-section
resolving power of at least 40 Ω/ΔΩ. The effective resolution with the conjoined ion mobility was
41,800,000 FWHM. The samples were ionized using a NanoLockSpray source (Waters, Manchester,
UK) in the positive ion mode of nanoESI (þ). The lock mass channel was sampled every 30 s.
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(100 fmol mL1) delivered through the reference sprayer of the NanoLockSpray source. The doubly
charged molecule [M þ 2H]2þ ¼ 785.8426 was used for initial single-point calibration and MS/MS
fragment ions of Glu-Fib, such as aþ , bþ , and yþ , were used to obtain the ﬁnal instrument calibration.
A Synapt G2-S HDMS instrument (Waters, Manchester, UK) was tuned to perform HDMSE multiplexed
DIA acquisition scanning with added speciﬁcity, orthogonality and selectivity and low and high col-
lision energies in a T-wave transfer cell [11]. The mass spectrometer was automatically set to
(a) switch between low energy MS (4 eV) and elevated collision energies HDMSE (19–45 eV) applied
to the transfer “T-wave” collision-induced dissociation (CID) cell ﬁlled with argon gas; and (b) adjust
the trap collision cell to 1 eV for the total ion current. The scan time was previously adjusted based on
the linear velocity of the chromatography peak delivered to the ion source to obtain a minimum of 20
scan points for each single peak, under both low-energy and high-energy transmission at an ortho-
gonal acceleration time-of-ﬂight (oa-TOF) and a range of 50–2000 m/z. The RF offset (MS proﬁle) was
adjusted, such that the nanoUPLC-HDMSE data were effectively transmitted from 400 to 2000 m/z,
ensuring that any masses observed in the high-energy spectra with less than 400 m/z arose from
dissociations in the collision cell.
Protein identiﬁcation and quantitative data packaging were performed as previously described
[1,12–15]. A cut-off Log2ratio values of þ1.0 (2-fold) or higher was applied for determining the
proteins with higher abundance levels and 1.0 (2-fold) or lower for proteins with lower abundance
levels to compare pairs of experimental groups [16,17]. In silico prediction of protein-protein inter-
action and pathways of HUVEC proteins, with different abundance levels after interaction, was per-
formed using QIAGEN's Ingenuity
s
Pathway Analysis (IPA
s
, QIAGEN Redwood City, www.qiagen.com/
ingenuity) and DAVID Bioinformatics Resources 6.7. The proteomic data were deposited in the Pro-
teomeXchange Consortium [18] via the PRIDE [19] partner repository with the dataset identiﬁer
PRIDE: PXD002823.
The list of proteins with different abundance ratio ﬁltered with 2-fold change criteria in Δugm1 vs.
control, WT vs. control; Δugm1 vs. WT; and GAG vs. control are presented in Tables 1–3. Pathways
related to Δugm1 (Δugm1 vs. control and Δugm1 vs. WT) interaction conditions are shown in Fig. 3.
Furthermore, coincident pathways between Δugm1 and GAG interaction conditions are shown in
Fig. 4. Fig. 5 exempliﬁes one of these coincident pathways (ILK signaling).Acknowledgments
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